| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31973d94de6256d5aae4938102b059e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-141 |
| filingDate |
2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c78421047aca67beab0eb7a90a7af40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b718513d2bceab522a200f55730781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de433ae0ec9a28335e6df36c6054d6fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6fa6765232983742715494be6d56ee |
| publicationDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016116603-A1 |
| titleOfInvention |
Novel phenylphosphates and use thereof as medicaments |
| abstract |
The present invention relates to novel phenylphosphates and naphthylphosphates, to the prodrugs thereof and to the (pharmaceutically) acceptable salts thereof, and to the use thereof as medicaments for the selective inhibition of the STAT5 protein, especially for use in cancer treatment. Advantageously, the novel compounds according to the general formula (I) and (II) inhibit the STAT5 protein by selective and specific interaction, these compounds having an activity at least 50 times higher for the selective inhibition of the STAT5 protein than currently known compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10882821-B1 |
| priorityDate |
2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |